Amantadine HCl Oral market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Amantadine HCl Oral market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Amantadine HCl Oral market is segmented into
Tablet
Capsules
Syrup
Segment by Application, the Amantadine HCl Oral market is segmented into
Parkinson's Disease
Influenza
Regional and Country-level Analysis
The Amantadine HCl Oral market is analysed and market size information is provided by regions (countries).
The key regions covered in the Amantadine HCl Oral market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Amantadine HCl Oral Market Share Analysis
Amantadine HCl Oral market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Amantadine HCl Oral business, the date to enter into the Amantadine HCl Oral market, Amantadine HCl Oral product introduction, recent developments, etc.
The major vendors covered:
Zydus Pharmaceuticals
Mylan
Teva
Vertical Pharmaceuticals
Adamas Pharmaceuticals
Upsher-Smith
Sandoz
Mikart Pharmaceuticals
Pharmaceutical Associates, Inc. (PAI)
Wockhardt Bio AG
CMP Pharma
Bionpharma
Graviti Pharma
Alembic Pharmaceuticals
Strides Pharma
Heritage Pharmaceuticals
1 Study Coverage
1.1 Amantadine HCl Oral Product Introduction
1.2 Market Segments
1.3 Key Amantadine HCl Oral Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Amantadine HCl Oral Market Size Growth Rate by Type
1.4.2 Tablet
1.4.3 Capsules
1.4.4 Syrup
1.5 Market by Application
1.5.1 Global Amantadine HCl Oral Market Size Growth Rate by Application
1.5.2 Parkinson's Disease
1.5.3 Influenza
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Amantadine HCl Oral Market Size, Estimates and Forecasts
2.1.1 Global Amantadine HCl Oral Revenue 2015-2026
2.1.2 Global Amantadine HCl Oral Sales 2015-2026
2.2 Global Amantadine HCl Oral, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Amantadine HCl Oral Historical Market Size by Region (2015-2020)
2.3.1 Global Amantadine HCl Oral Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Amantadine HCl Oral Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Amantadine HCl Oral Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Amantadine HCl Oral Sales Forecast by Region (2021-2026)
2.4.2 Global Amantadine HCl Oral Revenue Forecast by Region (2021-2026)
3 Global Amantadine HCl Oral Competitor Landscape by Players
3.1 Global Top Amantadine HCl Oral Sales by Manufacturers
3.1.1 Global Amantadine HCl Oral Sales by Manufacturers (2015-2020)
3.1.2 Global Amantadine HCl Oral Sales Market Share by Manufacturers (2015-2020)
3.2 Global Amantadine HCl Oral Manufacturers by Revenue
3.2.1 Global Amantadine HCl Oral Revenue by Manufacturers (2015-2020)
3.2.2 Global Amantadine HCl Oral Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Amantadine HCl Oral Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Amantadine HCl Oral Revenue in 2019
3.2.5 Global Amantadine HCl Oral Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Amantadine HCl Oral Price by Manufacturers
3.4 Global Amantadine HCl Oral Manufacturing Base Distribution, Product Types
3.4.1 Amantadine HCl Oral Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Amantadine HCl Oral Product Type
3.4.3 Date of International Manufacturers Enter into Amantadine HCl Oral Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Amantadine HCl Oral Market Size by Type (2015-2020)
4.1.1 Global Amantadine HCl Oral Sales by Type (2015-2020)
4.1.2 Global Amantadine HCl Oral Revenue by Type (2015-2020)
4.1.3 Amantadine HCl Oral Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Amantadine HCl Oral Market Size Forecast by Type (2021-2026)
4.2.1 Global Amantadine HCl Oral Sales Forecast by Type (2021-2026)
4.2.2 Global Amantadine HCl Oral Revenue Forecast by Type (2021-2026)
4.2.3 Amantadine HCl Oral Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Amantadine HCl Oral Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Amantadine HCl Oral Market Size by Application (2015-2020)
5.1.1 Global Amantadine HCl Oral Sales by Application (2015-2020)
5.1.2 Global Amantadine HCl Oral Revenue by Application (2015-2020)
5.1.3 Amantadine HCl Oral Price by Application (2015-2020)
5.2 Amantadine HCl Oral Market Size Forecast by Application (2021-2026)
5.2.1 Global Amantadine HCl Oral Sales Forecast by Application (2021-2026)
5.2.2 Global Amantadine HCl Oral Revenue Forecast by Application (2021-2026)
5.2.3 Global Amantadine HCl Oral Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Amantadine HCl Oral Market Size YoY Growth 2015-2026
6.1.1 Japan Amantadine HCl Oral Sales YoY Growth 2015-2026
6.1.2 Japan Amantadine HCl Oral Revenue YoY Growth 2015-2026
6.1.3 Japan Amantadine HCl Oral Market Share in Global Market 2015-2026
6.2 Japan Amantadine HCl Oral Market Size by Players (International and Local Players)
6.2.1 Japan Top Amantadine HCl Oral Players by Sales (2015-2020)
6.2.2 Japan Top Amantadine HCl Oral Players by Revenue (2015-2020)
6.3 Japan Amantadine HCl Oral Historic Market Review by Type (2015-2020)
6.3.1 Japan Amantadine HCl Oral Sales Market Share by Type (2015-2020)
6.3.2 Japan Amantadine HCl Oral Revenue Market Share by Type (2015-2020)
6.3.3 Japan Amantadine HCl Oral Price by Type (2015-2020)
6.4 Japan Amantadine HCl Oral Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Amantadine HCl Oral Sales Forecast by Type (2021-2026)
6.4.2 Japan Amantadine HCl Oral Revenue Forecast by Type (2021-2026)
6.4.3 Japan Amantadine HCl Oral Price Forecast by Type (2021-2026)
6.5 Japan Amantadine HCl Oral Historic Market Review by Application (2015-2020)
6.5.1 Japan Amantadine HCl Oral Sales Market Share by Application (2015-2020)
6.5.2 Japan Amantadine HCl Oral Revenue Market Share by Application (2015-2020)
6.5.3 Japan Amantadine HCl Oral Price by Application (2015-2020)
6.6 Japan Amantadine HCl Oral Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Amantadine HCl Oral Sales Forecast by Application (2021-2026)
6.6.2 Japan Amantadine HCl Oral Revenue Forecast by Application (2021-2026)
6.6.3 Japan Amantadine HCl Oral Price Forecast by Application (2021-2026)
7 North America
7.1 North America Amantadine HCl Oral Market Size YoY Growth 2015-2026
7.2 North America Amantadine HCl Oral Market Facts & Figures by Country
7.2.1 North America Amantadine HCl Oral Sales by Country (2015-2020)
7.2.2 North America Amantadine HCl Oral Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Amantadine HCl Oral Market Size YoY Growth 2015-2026
8.2 Europe Amantadine HCl Oral Market Facts & Figures by Country
8.2.1 Europe Amantadine HCl Oral Sales by Country
8.2.2 Europe Amantadine HCl Oral Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Amantadine HCl Oral Market Size YoY Growth 2015-2026
9.2 Asia Pacific Amantadine HCl Oral Market Facts & Figures by Country
9.2.1 Asia Pacific Amantadine HCl Oral Sales by Region (2015-2020)
9.2.2 Asia Pacific Amantadine HCl Oral Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Amantadine HCl Oral Market Size YoY Growth 2015-2026
10.2 Latin America Amantadine HCl Oral Market Facts & Figures by Country
10.2.1 Latin America Amantadine HCl Oral Sales by Country
10.2.2 Latin America Amantadine HCl Oral Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Amantadine HCl Oral Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Amantadine HCl Oral Market Facts & Figures by Country
11.2.1 Middle East and Africa Amantadine HCl Oral Sales by Country
11.2.2 Middle East and Africa Amantadine HCl Oral Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Zydus Pharmaceuticals
12.1.1 Zydus Pharmaceuticals Corporation Information
12.1.2 Zydus Pharmaceuticals Description and Business Overview
12.1.3 Zydus Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Zydus Pharmaceuticals Amantadine HCl Oral Products Offered
12.1.5 Zydus Pharmaceuticals Recent Development
12.2 Mylan
12.2.1 Mylan Corporation Information
12.2.2 Mylan Description and Business Overview
12.2.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Mylan Amantadine HCl Oral Products Offered
12.2.5 Mylan Recent Development
12.3 Teva
12.3.1 Teva Corporation Information
12.3.2 Teva Description and Business Overview
12.3.3 Teva Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Teva Amantadine HCl Oral Products Offered
12.3.5 Teva Recent Development
12.4 Vertical Pharmaceuticals
12.4.1 Vertical Pharmaceuticals Corporation Information
12.4.2 Vertical Pharmaceuticals Description and Business Overview
12.4.3 Vertical Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Vertical Pharmaceuticals Amantadine HCl Oral Products Offered
12.4.5 Vertical Pharmaceuticals Recent Development
12.5 Adamas Pharmaceuticals
12.5.1 Adamas Pharmaceuticals Corporation Information
12.5.2 Adamas Pharmaceuticals Description and Business Overview
12.5.3 Adamas Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Adamas Pharmaceuticals Amantadine HCl Oral Products Offered
12.5.5 Adamas Pharmaceuticals Recent Development
12.6 Upsher-Smith
12.6.1 Upsher-Smith Corporation Information
12.6.2 Upsher-Smith Description and Business Overview
12.6.3 Upsher-Smith Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Upsher-Smith Amantadine HCl Oral Products Offered
12.6.5 Upsher-Smith Recent Development
12.7 Sandoz
12.7.1 Sandoz Corporation Information
12.7.2 Sandoz Description and Business Overview
12.7.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sandoz Amantadine HCl Oral Products Offered
12.7.5 Sandoz Recent Development
12.8 Mikart Pharmaceuticals
12.8.1 Mikart Pharmaceuticals Corporation Information
12.8.2 Mikart Pharmaceuticals Description and Business Overview
12.8.3 Mikart Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Mikart Pharmaceuticals Amantadine HCl Oral Products Offered
12.8.5 Mikart Pharmaceuticals Recent Development
12.9 Pharmaceutical Associates, Inc. (PAI)
12.9.1 Pharmaceutical Associates, Inc. (PAI) Corporation Information
12.9.2 Pharmaceutical Associates, Inc. (PAI) Description and Business Overview
12.9.3 Pharmaceutical Associates, Inc. (PAI) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Products Offered
12.9.5 Pharmaceutical Associates, Inc. (PAI) Recent Development
12.10 Wockhardt Bio AG
12.10.1 Wockhardt Bio AG Corporation Information
12.10.2 Wockhardt Bio AG Description and Business Overview
12.10.3 Wockhardt Bio AG Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Wockhardt Bio AG Amantadine HCl Oral Products Offered
12.10.5 Wockhardt Bio AG Recent Development
12.11 Zydus Pharmaceuticals
12.11.1 Zydus Pharmaceuticals Corporation Information
12.11.2 Zydus Pharmaceuticals Description and Business Overview
12.11.3 Zydus Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Zydus Pharmaceuticals Amantadine HCl Oral Products Offered
12.11.5 Zydus Pharmaceuticals Recent Development
12.12 Bionpharma
12.12.1 Bionpharma Corporation Information
12.12.2 Bionpharma Description and Business Overview
12.12.3 Bionpharma Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Bionpharma Products Offered
12.12.5 Bionpharma Recent Development
12.13 Graviti Pharma
12.13.1 Graviti Pharma Corporation Information
12.13.2 Graviti Pharma Description and Business Overview
12.13.3 Graviti Pharma Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Graviti Pharma Products Offered
12.13.5 Graviti Pharma Recent Development
12.14 Alembic Pharmaceuticals
12.14.1 Alembic Pharmaceuticals Corporation Information
12.14.2 Alembic Pharmaceuticals Description and Business Overview
12.14.3 Alembic Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Alembic Pharmaceuticals Products Offered
12.14.5 Alembic Pharmaceuticals Recent Development
12.15 Strides Pharma
12.15.1 Strides Pharma Corporation Information
12.15.2 Strides Pharma Description and Business Overview
12.15.3 Strides Pharma Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Strides Pharma Products Offered
12.15.5 Strides Pharma Recent Development
12.16 Heritage Pharmaceuticals
12.16.1 Heritage Pharmaceuticals Corporation Information
12.16.2 Heritage Pharmaceuticals Description and Business Overview
12.16.3 Heritage Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Heritage Pharmaceuticals Products Offered
12.16.5 Heritage Pharmaceuticals Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Amantadine HCl Oral Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Amantadine HCl Oral Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Zydus Pharmaceuticals
Mylan
Teva
Vertical Pharmaceuticals
Adamas Pharmaceuticals
Upsher-Smith
Sandoz
Mikart Pharmaceuticals
Pharmaceutical Associates, Inc. (PAI)
Wockhardt Bio AG
CMP Pharma
Bionpharma
Graviti Pharma
Alembic Pharmaceuticals
Strides Pharma
Heritage Pharmaceuticals
*If Applicable.